Q2 2025 Policy Report: Advancing Our Strategic Priorities
This report outlines the key accomplishments and progress we made in the second quarter—both on your behalf and for the broader medtech industry. While addressing tariffs remained a top focus, we’re proud to report meaningful strides across all pillars of our strategic plan, reflecting the dedication and impact of our team.
Explore the full Q2 2025 report and join us in shaping the future of medtech policy.